BIDMC clinician-researchers provide new evidence about the optimal way to treat patients who carry BRCA mutations who have been diagnosed with breast cancer.
Platinum-based agents not superior to standard chemotherapy
- EurekAlert
- 4. 3 2020 (06:00)
BIDMC clinician-researchers provide new evidence about the optimal way to treat patients who carry BRCA mutations who have been diagnosed with breast cancer.